Recent Advances in Perioperative Immunotherapies in Lung Cancer

Several clinical trials have been revolutionizing the perioperative treatment of early-stage non-small cell lung cancer (NSCLC). Many of these clinical trials involve cancer immunotherapies with antibody drugs that block the inhibitory immune checkpoints programmed death 1 (PD-1) and its ligand PD-L...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukuda, Shota, Suda, Kenichi, Hamada, Akira, Tsutani, Yasuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526295/
https://www.ncbi.nlm.nih.gov/pubmed/37759777
http://dx.doi.org/10.3390/biom13091377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526295/
https://www.ncbi.nlm.nih.gov/pubmed/37759777
http://dx.doi.org/10.3390/biom13091377

Ejemplares similares